Total colectomy

OPER_JFH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^JFH 1 out of 7 registries used, show all original rules.	1577
4. Check minimum number of events None	1577
5. Include endpoints None	1577
6. Filter based on genotype QC (FinnGen only)	1577

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	OPER_JFH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^JFH
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Total colectomy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Total colectomy operation

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1577	753	824
Unadjusted period prevalence (%)	0.31	0.26	0.36
Median age at first event (years)	51.90	48.36	55.15

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1421: Matched controls
14210

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

26.2

323.0

728

547

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

323.0

320

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

59.2

323.0

646

197

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

1616.9

323.0

517

WX302

NOMESCO Finland

Thoracal epidural anesthesy

31.4

323.0

571

297

K51.8

ICD-10 Finland

Other ulcerative colitis

74.8

323.0

376

L04AX01

ATC

azathioprine; systemic

39.4

323.0

654

301

A07EA02

ATC

hydrocortisone; rectal

58.5

323.0

473

120

JFH10

NOMESCO Finland

Total colectomy and ileostomy

+∞

323.0

323

K51.5

ICD-10 Finland

Left sided colitis

100.7

323.0

739

151

A07EC02

ATC

mesalazine; oral, rectal

55.1

323.0

839

362

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

65.7

323.0

843

308

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

164.8

323.0

394

UJF32

NOMESCO Finland

Coloscopy

11.7

323.0

958

2141

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

49.9

304.7

369

A07EA06

ATC

budesonide; oral, local oral

28.5

295.5

413

201

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

+∞

290.9

269

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

794.9

273.7

261

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

160.3

253.4

262

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

30.8

252.2

343

145

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

90.6

236.4

260

ZXE20

NOMESCO Finland

More than three and less than five hours

8.5

215.6

550

982

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

10.4

209.9

458

623

J01MA02

ATC

ciprofloxacin; systemic

5.4

189.0

910

3539

WX408

NOMESCO Finland

General anesthesy, balanced

5.3

175.6

742

2428

H02AB06

ATC

prednisolone; systemic

5.0

171.9

985

4424

Z93.2

ICD-10 Finland

Ileostomy status

152.3

166.5

174

JN3BD

NOMESCO Finland

Extensive abdominal CT

7.8

165.3

429

742

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

32.8

163.9

218

UJF30

NOMESCO Finland

Ileoscopy through colon

8.1

158.3

400

659

B01AB05

ATC

enoxaparin; parenteral

4.8

156.0

719

2490

P01AB01

ATC

metronidazole; oral, rectal

4.5

155.3

881

3749

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

+∞

152.9

144

JFF10

NOMESCO Finland

Loop enterostomy

83.0

151.4

169

K51

ICD-10 Finland

Ulcerative colitis

57.6

150.0

177

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

+∞

147.5

139

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.7

145.9

679

2330

JAH00

NOMESCO Finland

Laparotomy

18.4

137.5

219

139

H02AB07

ATC

prednisone; oral

5.9

136.7

446

1019

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

15.5

136.4

233

177

ZX120

NOMESCO Finland

Intravenous

7.5

135.7

357

610

JFH11

NOMESCO Finland

Laparoscopic colectomy

+∞

129.2

122

TPH04

NOMESCO Finland

Cathetrisation of vein

4.6

127.6

554

1717

K50.1

ICD-10 Finland

Crohn disease of large intestine

31.2

127.2

171

TPH07

NOMESCO Finland

Cathetrisation of artery

6.7

126.1

358

675

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

10.9

122.1

247

268

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

25.4

121.5

173

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.0

116.4

644

2457

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

58.2

116.3

137

TJF80

NOMESCO Finland

Ostomy education

45.0

115.0

142

K50.9

ICD-10 Finland

Crohn disease, unspecified

23.9

113.2

164

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

19.0

111.7

175

104

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

+∞

110.9

105

K50.8

ICD-10 Finland

Other Crohn disease

22.8

109.5

161

UJG02

NOMESCO Finland

Proctoscopy

16.4

106.8

177

122

L01BB02

ATC

mercaptopurine; oral

28.0

104.2

144

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

4.4

103.9

452

1354

ZXD05

NOMESCO Finland

Urgent procedure

3.6

103.5

673

2858

D94

ICPC

Chronic enteritis/ulcerative colitis

56.8

101.5

120

K56.7

ICD-10 Finland

Ileus, unspecified

26.6

101.3

142

A07EC01

ATC

sulfasalazine; oral, rectal

6.4

100.5

292

553

JN3AD

NOMESCO Finland

Abdominal CT examination

6.4

96.9

282

533

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

64.8

93.3

108

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.0

93.1

248

414

WX402

NOMESCO Finland

General anaesthesia

4.1

92.2

428

1339

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

26.9

91.8

128

ZXE10

NOMESCO Finland

More than one and less than three hours

3.2

90.8

703

3307

H02AB09

ATC

hydrocortisone; systemic

13.3

89.6

162

136

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

5.0

88.9

321

778

A07EA01

ATC

prednisolone; rectal

51.9

88.3

106

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

12.0

86.3

164

153

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

85.7

779

4041

JFF13

NOMESCO Finland

Terminal enterostomy

137.1

85.0

A06AC01

ATC

ispaghula (psylla seeds); oral

3.5

84.5

494

1857

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

9.4

82.6

179

214

JFB00

NOMESCO Finland

Partial resection of small intestine

23.1

81.6

119

K50.0

ICD-10 Finland

Crohn disease of small intestine

18.2

77.1

122

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

73.2

671

3376

B01AB10

ATC

tinzaparin; parenteral

5.8

69.6

212

414

JFH96

NOMESCO Finland

Other total colectomy

+∞

68.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.6

67.4

185

315

K56.0

ICD-10 Finland

Paralytic ileus

34.2

66.7

SPAT1262

SPAT

Handing over of treatment supplies

3.3

66.2

400

1493

R4110

NOMESCO Finland

Physiotherapy

2.9

65.3

509

2267

UJF92

NOMESCO Finland

Capsular endoscopy

11.5

65.0

125

118

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

7.0

64.6

169

269

4AA12

NOMESCO Finland

67.8

61.9

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

66.8

60.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.5

60.5

238

611

N02BE01

ATC

paracetamol; systemic, rectal

3.5

60.3

1268

9983

A02BC02

ATC

pantoprazole; systemic

2.6

59.8

992

6710

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

86.5

59.5

A07DA03

ATC

loperamide; oral

8.1

59.0

138

185

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

25.9

57.8

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

20.7

57.3

ZXD10

NOMESCO Finland

Scheduled procedure

2.5

57.2

648

3529

Z93

ICD-10 Finland

Artificial opening status

50.9

56.7

K83.0

ICD-10 Finland

Cholangitis

17.4

56.3

WX002

NOMESCO Finland

Sedation and analgesia

3.0

56.0

383

1535

WX600

NOMESCO Finland

Single shot through catheter

12.4

55.8

103

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.9

55.0

407

1715

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.3

54.8

126

164

D99

ICPC

Disease digestive system other

24.2

54.6

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

23.2

54.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

54.5

299

1018

L04AB04

ATC

adalimumab; parenteral

11.9

54.2

102

E86

ICD-10 Finland

Volume depletion

10.5

52.9

106

108

JF2AB

NOMESCO Finland

Colongraphy with X-ray

47.7

52.7

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

11.1

52.5

102

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.7

51.8

191

456

ZXE00

NOMESCO Finland

One hour or less

2.4

51.7

668

3838

L04AD01

ATC

ciclosporin; systemic

10.1

51.4

105

111

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

24.0

51.0

N02AX02

ATC

tramadol; systemic, rectal

2.4

50.8

675

3919

JFH01

NOMESCO Finland

Laparoscopic colectomy with ileorectal anastomosis

+∞

50.3

SPAT1125

SPAT

Stoma care and guidance

14.8

49.5

130

Kela drug reimbursment

Malignant tumour

4.4

49.4

193

487

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

110.0

49.1

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

54.9

49.0

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

16.4

48.0

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

5.6

47.6

146

283

L01BC06

ATC

capecitabine; oral

7.1

47.4

121

184

ZXC86

NOMESCO Finland

Use of endoscopic device

41.0

47.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.5

46.7

146

289

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

472.6

46.6

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

88.2

46.1

J01MA12

ATC

levofloxacin; systemic

2.8

45.7

347

1463

Z43.2

ICD-10 Finland

Attention to ileostomy

101.4

45.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

14.5

44.5

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

25.9

44.4

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

66.0

44.4

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

30.7

44.3

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

43.9

353

1535

WX306

NOMESCO Finland

Lumbar epidural anesthesy

4.5

43.6

164

397

N03AX16

ATC

pregabalin; oral

2.6

43.4

405

1918

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.3

43.2

120

205

A05AA02

ATC

ursodeoxycholic acid; oral

10.8

42.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

10.4

42.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

41.7

290

1149

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

79.3

41.1

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

14.0

41.1

JN4BD

NOMESCO Finland

Extensive body CT

3.3

41.0

230

782

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

+∞

40.8

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.6

40.6

149

351

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.9

40.6

178

497

K65.0

ICD-10 Finland

Acute peritonitis

13.6

39.4

JHA00

NOMESCO Finland

Anal or perianal incision

10.8

39.4

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

26.7

39.1

3AC01

NOMESCO Finland

14.4

38.6

K56.2

ICD-10 Finland

Volvulus

25.0

37.7

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

13.8

37.5

4AB02

NOMESCO Finland

43.1

37.4

D18

ICPC

Change in faeces/bowel movements

9.5

36.8

A07EC03

ATC

olsalazine; oral

55.3

36.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.7

36.3

172

511

JKA20

NOMESCO Finland

Cholecystectomy

7.7

35.6

117

WZC30

NOMESCO Finland

Teaching

2.9

35.5

248

974

C10AC01

ATC

colestyramine; oral

7.3

35.2

126

R50.9

ICD-10 Finland

Fever, unspecified

2.7

35.2

266

1099

Z2221

NOMESCO Finland

Medical doctor

2.2

34.9

457

2516

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

7.3

34.7

125

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

4.6

34.5

127

299

N02AA05

ATC

oxycodone; systemic

2.8

33.8

239

944

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

32.9

525

3130

Z3231

NOMESCO Finland

Registered nurse

2.2

32.4

435

2403

TQW40

NOMESCO Finland

Remowal of suture of skin

3.7

32.1

152

450

K92.1

ICD-10 Finland

Melaena

4.5

32.1

119

282

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

35.1

32.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.9

31.9

141

394

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

15.8

31.8

4AA33

NOMESCO Finland

168.7

31.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.6

31.1

149

445

RD210

NOMESCO Finland

8.5

31.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.7

30.8

168

S18

ICPC

Laceration/cut

2.0

30.7

604

3881

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

30.5

221

883

JHD00

NOMESCO Finland

Anal dilatation

16.3

30.4

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

59.7

30.2

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

19.0

30.2

Z93.3

ICD-10 Finland

Colostomy status

19.0

30.2

UJF34

NOMESCO Finland

Left colonoscopy

21.6

30.1

K60.3

ICD-10 Finland

Anal fistula

7.2

29.8

108

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

26.3

29.8

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.1

29.7

120

309

K59.0

ICD-10 Finland

Constipation

4.1

29.0

120

316

JAH01

NOMESCO Finland

Laparoscopy

4.5

28.9

107

253

Z2446

NOMESCO Finland

Social worker

3.5

28.8

145

450

L04AC05

ATC

ustekinumab; parenteral

23.4

28.8

Z3226

NOMESCO Finland

Physiotherapist

2.3

28.7

306

1504

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.1

28.6

196

JF1BD

NOMESCO Finland

Very extensive small bowel CT

16.3

28.6

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

9.6

28.6

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

7.0

28.2

106

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

43.4

27.8

K61.0

ICD-10 Finland

Anal abscess

7.7

27.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

27.4

183

693

WX892

NOMESCO Finland

Monitored bed care

3.2

27.3

152

507

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

27.2

228

988

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.9

26.9

137

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.8

26.7

117

324

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

9.0

26.6

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

22.9

26.6

L04AA01

ATC

[U] ciclosporin; systemic

7.9

26.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

52.7

26.3

B80

ICPC

Iron deficiency anaemia

7.3

25.8

UJK02

NOMESCO Finland

ERCP

6.8

25.8

101

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

11.8

25.5

JN4AD

NOMESCO Finland

Body CT examination

3.2

25.5

143

480

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

51.0

25.3

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

6.1

25.2

120

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.5

25.2

3005

Kela drug reimbursment

Tofacitinib

39.6

24.9

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

71.2

24.9

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.9

24.8

126

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.3

24.4

109

1370

FHL

Colonoscopy, whole colon

20.5

24.4

WW500

NOMESCO Finland

Blood transfusion

4.2

24.2

243

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.8

24.2

168

651

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

24.1

212

939

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

24.0

251

1215

UJK12

NOMESCO Finland

Peroral cholangioscopy

38.3

24.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.5

23.7

134

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

23.6

164

633

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.6

23.5

188

R11

ICD-10 Finland

Nausea and vomiting

3.0

23.4

142

501

J01DB01

ATC

cefalexin; oral

2.0

23.2

1155

9791

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.0

23.1

159

JFA70

NOMESCO Finland

Suture of small intestine

25.1

23.1

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

55.0

23.1

K51.4

ICD-10 Finland

Inflammatory polyps

55.0

23.1

R4190

NOMESCO Finland

Nutritional therapy

4.4

23.0

201

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

13.8

22.8

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

84.8

22.7

B03BA03

ATC

hydroxocobalamin; parenteral

3.7

22.6

104

300

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

32.8

22.5

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

15.4

22.0

SPAT1255

SPAT

Intravenous administration of medicine

3.2

22.0

120

396

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

21.4

244

1226

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

23.5

21.3

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

10.0

20.6

WX610

NOMESCO Finland

Patient controlled analgesia

12.7

20.4

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

48.7

20.2

A07AA11

ATC

rifaximin; oral

48.7

20.2

JAH33

NOMESCO Finland

Opening of laparostomy

58.4

19.9

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

19.8

173

760

WVA20

NOMESCO Finland

Medicine administration

5.5

19.8

111

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.6

19.8

107

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.9

19.8

227

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

74.6

19.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.8

19.6

234

K59.3

ICD-10 Finland

Megacolon, not elsewhere classified

40.7

19.5

UJF02

NOMESCO Finland

Peroral enteroscopy

12.9

19.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

19.4

110

372

A28

ICPC

Limited function/disability NOS

2.3

19.3

193

908

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.7

19.3

102

JF1AD

NOMESCO Finland

Small bowel CT

15.8

19.3

A07AA09

ATC

vancomycin; oral

8.5

19.3

A04AA02

ATC

granisetron; systemic, transdermal

3.2

18.9

103

339

D75

ICPC

Malignant neoplasm colon/rectum

13.0

18.9

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

600

836

10.97

307.65

2.7

1.6

—

(3022145) Colonoscopy Study observation

717

1393

8.60

307.65

2.7

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

669

1583

6.60

290.05

6.2

2.5

ug/g

485.8

127.2

28.44

626

1271

(3024561) Albumin [Mass/volume] in Serum or Plasma

1231

5118

7.40

280.26

15.4

5.0

g/l

33.2

35.8

41.64

1202

4787

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

518

1166

6.13

231.08

3.6

2.3

g/l

0.2

2.10

499

1091

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

476

1136

5.57

196.02

7.1

4.3

ug/l

8.7

24.5

1.21

382

933

(3014576) Chloride [Moles/volume] in Serum or Plasma

544

1480

5.08

191.51

14.7

7.3

mmol/l

104.5

104.4

0.24

537

1446

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1237

6388

5.34

183.06

12.2

6.3

umol/l

10.8

11.7

2.06

1215

6059

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

234

285

9.47

182.72

3.9

5.9

iu/ml

373.5

431.7

0.13

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

521

1429

4.95

180.39

4.5

2.9

umol/l

6.1

8.7

2.40

470

1245

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

465

1165

5.24

179.57

3.5

2.5

u/l

44.2

81.6

0.44

436

997

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

274

414

7.80

178.53

1.7

1.6

iu/ml

0.1

0.2

0.62

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

914

3839

4.28

178.02

4.4

2.5

u/l

60.4

56.8

1.75

896

3567

(3023368) Bacteria identified in Blood by Culture

816

3261

4.11

168.27

7.2

4.2

—

(3032080) INR in Blood by Coagulation assay

1017

4809

4.14

162.49

11.1

8.9

inr

1.1

1.2

4.49

325

1433

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

227

308

8.44

161.84

1.6

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

527

1601

4.44

157.63

3.3

2.5

18.0

23.8

16.61

467

1388

(3022948) Iron [Moles/volume] in Serum or Plasma

573

1863

4.26

156.16

3.4

2.5

umol/l

11.0

13.6

12.49

556

1727

(3004789) Transferrin [Mass/volume] in Serum or Plasma

542

1714

4.29

153.03

3.3

2.5

g/l

2.4

2.3

2.06

523

1599

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1126

5863

4.22

152.77

7.3

4.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

749

3038

3.79

146.54

4.2

2.1

mg/l

3.3

2.9

4.15

698

2593

(3044640) Blood type and Crossmatch panel - Blood

870

3900

3.75

145.84

4.5

2.4

—

(42870588) Differential panel, method unspecified - Blood

897

4265

3.56

133.75

11.0

6.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

884

4260

3.45

127.05

6.2

3.3

u/l

34.8

32.9

0.29

862

4048

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

704

2984

3.46

124.16

4.3

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

972

5033

3.43

122.68

3.9

2.2

nmol/l

70.8

75.7

7.15

933

4564

(3013650) Neutrophils [#/volume] in Blood by Automated count

1226

7341

4.01

122.37

17.7

9.2

e9/l

4.5

4.1

8.85

1145

6422

(3022096) Basophils/100 leukocytes in Blood

1059

5794

3.52

121.67

12.9

6.2

0.6

0.7

0.75

1020

5430

(3019069) Monocytes/100 leukocytes in Blood

1082

6016

3.54

120.69

13.1

6.4

8.6

0.18

1041

5655

(3006504) Eosinophils/100 leukocytes in Blood

1076

5979

3.52

119.78

12.8

6.1

2.5

2.8

4.68

1034

5589

(3025941) Bacteria identified in Stool by Culture

301

719

4.94

119.62

1.7

1.2

—

(3001604) Monocytes [#/volume] in Blood

1115

6339

3.59

119.43

12.7

5.9

e9/l

0.6

5.49

1029

5504

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

20.93

119.22

2.2

3.3

au/ml

159.8

32.7

—

(3006315) Basophils [#/volume] in Blood

1117

6366

3.59

118.97

12.7

5.9

e9/l

0.0

1.46

1033

5534

(3002030) Lymphocytes/100 leukocytes in Blood

1098

6200

3.54

118.55

12.8

6.1

25.4

28.2

15.88

1054

5801

(3042936) Bacteria identified in Isolate by Culture

508

1799

3.69

117.94

2.9

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

717

3153

3.34

117.69

8.8

4.0

94.8

90.7

4.29

708

3072

(3019198) Lymphocytes [#/volume] in Blood

1131

6532

3.59

117.08

12.7

6.0

e9/l

1.8

2.0

1.32

1053

5783

(3013115) Eosinophils [#/volume] in Blood

1134

6586

3.57

115.74

13.0

6.3

e9/l

0.2

0.91

1052

5810

(3020779) Urea [Moles/volume] in Serum or Plasma

373

1091

4.17

113.81

10.1

7.9

mmol/l

9.9

9.2

0.86

357

1043

(3013826) Glucose [Moles/volume] in Serum or Plasma

1199

7262

3.72

113.19

9.1

4.8

mmol/l

6.8

6.7

1.07

1157

6784

(3018010) Neutrophils/100 leukocytes in Blood

1075

6105

3.39

112.53

12.3

5.9

60.0

57.0

14.07

1034

5743

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

221

426

5.87

111.72

6.1

3.5

u/ml

69.9

3373.3

0.79

198

362

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1413

9612

5.52

111.50

20.1

7.4

u/l

85.1

77.5

7.07

1388

9064

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1044

5877

3.30

109.88

12.1

6.8

mmol/l

1.2

11.48

916

4975

(3012095) Magnesium [Moles/volume] in Serum or Plasma

519

2000

3.38

103.71

7.0

3.5

mmol/l

0.8

1.15

493

1881

(3003458) Phosphate [Moles/volume] in Serum or Plasma

449

1599

3.53

101.53

8.7

6.1

mmol/l

1.0

0.11

429

1484

(3001122) Ferritin [Mass/volume] in Serum or Plasma

983

5548

3.05

98.95

5.2

2.7

ug/l

101.2

127.0

2.73

936

5171

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

953

5340

2.98

96.24

11.7

6.1

mmol/l

1.2

5.94

908

4867

(40768804) Tissue Pathology biopsy report

902

4940

2.93

94.46

3.2

2.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

341

1059

3.83

94.23

9.4

7.7

mmol/l

1.4

0.03

330

1020

(3000991) Gas panel - Venous blood

319

997

3.76

86.84

12.9

9.1

—

(3026782) Osmolality of Urine

545

2364

2.99

86.50

3.6

2.7

mosm/kgh2o

530.4

557.8

1.92

501

2027

(3002582) Erythrocytes [#/volume] in Urine

717

3644

2.77

83.83

4.3

3.2

e6/l

79.9

78.2

0.01

605

2813

(3030467) Casts [#/volume] in Urine by Automated count

668

3323

2.75

80.76

4.2

3.1

e6/l

0.8

0.4

1.22

552

2505

(3021447) Carbon dioxide [Partial pressure] in Venous blood

327

1090

3.52

80.29

7.2

3.8

kpa

5.8

5.9

0.60

315

1061

(3002032) Base excess in Venous blood by calculation

323

1083

3.49

78.45

7.2

3.8

mmol/l

1.3

1.9

1.75

254

869

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

16.49

76.44

2.4

2.0

mg/l

8.5

9.5

0.41

(3016502) Oxygen saturation in Arterial blood

343

1216

3.33

76.01

12.9

8.6

96.8

95.8

1.73

332

1174

(3000850) Epithelial cells [#/volume] in Urine

543

2503

2.78

75.17

3.5

2.5

e6/l

6.6

5.5

0.59

498

2213

(3002173) Hemoglobin [Mass/volume] in Arterial blood

326

1131

3.37

74.73

13.3

8.9

g/l

116.0

122.6

6.33

318

1090

(3003396) Base excess in Arterial blood by calculation

361

1338

3.20

74.15

12.4

8.3

mmol/l

0.3

1.2

2.80

295

1062

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

361

1342

3.19

73.74

12.4

8.3

kpa

5.0

5.1

1.23

351

1291

(3027801) Oxygen [Partial pressure] in Arterial blood

361

1343

3.19

73.63

12.4

8.3

kpa

14.3

12.4

7.60

351

1295

(3018418) pH of Serum or Plasma

666

3449

2.61

72.44

5.7

4.0

7.4

2.28

140

671

(3017143) Hepatitis C virus Ab [Presence] in Serum

409

1649

3.00

72.37

1.5

1.6

—

(36304419) Bacteria [Presence] in Urine

639

3270

2.60

70.91

4.1

3.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

828

4793

2.53

70.62

2.5

1.9

pmol/l

96.4

95.2

0.29

503

2581

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

101.16

70.56

2.4

4.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

140

268

5.64

70.52

1.9

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

116

192

6.44

67.84

2.4

1.7

g/l

1.0

0.9

0.21

149

(3018095) Leukocytes [#/volume] in Urine

758

4272

2.49

67.65

5.0

3.6

e6/l

138.1

92.9

0.32

625

3021

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

224

651

3.84

66.87

15.5

11.1

—

(3021589) Normoblasts [#/volume] in Blood

907

5592

2.46

65.76

21.2

9.3

e9/l

0.0

0.04

797

4608

(3007566) Smooth muscle Ab [Titer] in Serum

161

370

4.73

65.63

1.8

1.2

titre

78.5

90.0

0.19

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

160

368

4.73

65.14

4.1

2.9

u/ml

0.3

0.4

4.25

206

(3036481) Cortisol [Moles/volume] in Serum or Plasma

315

1171

3.11

63.57

2.9

2.1

nmol/l

354.6

372.3

0.75

300

1085

(3017181) Myelocytes/100 leukocytes in Blood

291

1042

3.20

62.54

5.0

4.5

1.1

1.0

0.23

126

302

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

104

8.37

62.26

1.3

1.1

titre

254.0

162.9

0.45

(3005719) IgG [Mass/volume] in Serum or Plasma

278

991

3.19

60.04

2.9

2.7

g/l

11.6

10.6

2.86

257

908

(3013707) Erythrocyte sedimentation rate by Westergren method

1261

9268

2.80

59.73

6.8

3.9

mm/h

16.0

11.2

21.11

1207

8604

(3007853) Bacteria identified in Skin by Aerobe culture

359

1488

2.83

59.14

2.2

1.7

—

(3026008) Bacteria identified in Urine by Culture

617

3322

2.41

58.94

3.5

2.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

260

901

3.26

58.80

5.8

3.0

kpa

4.6

0.00

251

872

(3028026) IgM [Mass/volume] in Serum or Plasma

238

784

3.40

58.42

2.1

1.8

g/l

1.2

1.4

0.86

223

729

(40758558) Short blood count panel - Blood

587

3121

2.40

57.37

13.4

6.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

112

7.67

57.17

2.1

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1139

8054

2.49

57.04

5.8

4.1

e6/l

98.7

2354.5

1.84

112

(3009445) Proteinase 3 Ab [Units/volume] in Serum

184

521

3.87

56.69

1.7

1.4

u/ml

2.9

10.4

1.55

(4035726)

280

1037

3.07

56.41

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

198

593

3.67

56.20

7.3

4.1

mmol/l

23.5

24.2

2.02

188

539

(3002179) Metamyelocytes/100 leukocytes in Blood

263

952

3.12

55.06

4.7

4.3

0.7

0.6

0.45

224

(3021440) Promyelocytes/100 leukocytes in Blood

267

990

3.04

53.51

5.2

4.5

0.1

0.70

114

279

(3021960) Folate [Moles/volume] in Serum or Plasma

524

2723

2.38

53.19

1.8

1.5

nmol/l

22.9

20.5

0.80

464

2343

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

158

421

4.06

52.91

1.9

1.5

titre

360.0

161.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

409

1924

2.52

51.48

3.3

2.9

e6/l

2.5

2.0

0.43

232

1053

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

440

2158

2.44

50.45

1.5

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

424

2052

2.46

50.01

2.1

1.7

nmol/l

1147.4

1190.5

0.41

348

1578

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

420

2024

2.47

50.00

3.1

2.7

e6/l

1.1

1.0

0.34

244

1150

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

101

196

5.44

49.90

4.4

2.8

u/ml

4.9

88.6

0.69

101

184

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

483

2482

2.36

49.75

2.0

1.6

pmol/l

449.5

32013787.8

2.38

428

2096

(3037467) Urinalysis macro (dipstick) panel - Urine

1158

8560

2.33

47.43

5.8

4.0

—

(3037522) Nuclear Ab [Titer] in Serum

370

1731

2.49

46.60

1.6

1.3

titre

472.4

461.2

0.04

340

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

5.89

46.60

2.1

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

157

5.81

46.44

2.1

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

9.18

45.64

13.0

31.1

ug/l

136.0

130.5

0.17

(3025159) Blasts/100 leukocytes in Blood

243

935

2.89

45.13

5.3

4.6

0.0

0.5

0.71

237

(40760892) CBC W Ordered Manual Differential panel - Blood

524

2901

2.21

44.26

8.2

4.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

157

5.67

44.26

2.2

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

154

5.71

44.09

2.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

154

5.71

44.09

2.1

1.5

—

(3003181) Sodium [Moles/volume] in Urine

188

5.19

43.85

3.3

1.3

mmol/l

60.5

63.9

0.16

162

(3005988) Vibrio sp identified in Specimen by Organism specific culture

155

5.67

43.78

2.1

1.5

—

(40768797) Stomach Pathology biopsy report

360

1716

2.42

43.17

1.6

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

135

381

3.78

41.50

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

387

3.75

41.31

1.4

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

134

379

3.77

41.06

1.5

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

150

462

3.48

40.44

1.2

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

290

1301

2.51

39.38

2.7

2.8

1.9

1.8

0.56

266

1177

(3015377) Calcium [Moles/volume] in Serum or Plasma

641

3978

2.03

38.95

5.0

3.4

mmol/l

2.3

2.4

2.06

583

3533

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

381

1945

2.26

38.50

2.1

1.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

133

393

3.60

38.16

3.5

2.6

g/l

3.5

3.6

0.32

127

374

(3052851) Hemolysis interference index of Serum or Plasma

124

355

3.71

37.27

4.5

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

149

483

3.30

36.97

11.7

5.6

0.9

0.44

144

451

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

149

485

3.29

36.72

11.7

5.6

1.5

1.6

0.53

144

453

(3004809) Band form neutrophils/100 leukocytes in Blood

191

4.70

36.28

2.8

3.7

2.4

1.5

0.60

162

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

102

262

4.09

35.71

6.7

3.8

60.1

57.0

1.49

102

262

(3030905) Polymorphonuclear cells [#/volume] in Blood

100

254

4.14

35.54

6.2

3.5

e9/l

4.5

4.2

0.54

100

254

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

80.04

34.96

2.1

1.6

mg/l

3.3

4.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

106

6.05

34.94

2.1

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

191

740

2.80

34.62

13.5

7.5

mmol/l

23.8

24.5

1.31

180

693

(3004119) Hemoglobin [Mass/volume] in Venous blood

185

710

2.82

34.12

5.4

3.1

g/l

124.4

129.7

1.98

179

697

(3019060) Gas panel - Arterial blood

196

787

2.70

33.10

10.7

5.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1478

12888

3.34

32.48

41.7

13.3

mg/l

27.2

23.4

5.17

1396

10122

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

228

4.13

32.08

6.7

3.9

u/ml

207.5

1343.5

0.54

215

(3023520) Reticulocytes [#/volume] in Blood

218

948

2.51

31.21

2.5

3.0

e9/l

76.2

71.4

0.85

167

732

(3002256) Pathology report gross observation

308

1572

2.19

30.41

1.4

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1481

13058

3.20

29.30

42.4

14.9

mmol/l

138.8

139.7

39.40

1466

12724

(46235355) HIV 1 and 2 tests - Meaningful Use set

448

2665

1.95

28.99

1.7

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

135

478

3.00

28.72

2.4

2.0

ug/l

13.3

1.7

0.60

126

434

(3023103) Potassium [Moles/volume] in Serum or Plasma

1482

13097

3.18

28.69

42.5

15.0

mmol/l

4.0

1.45

1465

12742

(3021879) Hepatitis B virus core Ab [Presence] in Serum

234

1091

2.34

28.59

1.3

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.93

28.52

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.93

28.52

1.7

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

429

2544

1.94

27.85

1.9

1.5

g/l

2.7

2.4

2.26

312

1607

(40768441) Liver Pathology biopsy report

108

5.34

27.79

1.8

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

191

4.13

27.37

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

114

381

3.15

26.78

14.5

6.6

mmol/l

1.3

0.10

103

335

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

138

516

2.83

26.57

1.7

2.0

g/l

1.6

1.5

0.68

127

457

(3027273) Bicarbonate [Moles/volume] in Venous blood

139

530

2.78

25.78

6.6

3.2

mmol/l

24.3

25.3

1.98

134

516

(3036489) Thrombin time

132

490

2.85

25.74

3.3

2.2

21.2

21.3

0.13

122

437

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

250

1260

2.17

25.13

5.1

3.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

173

4.13

24.93

9.1

5.9

mg/l

11.1

11.0

0.02

157

(3000494) Fungus identified in Specimen by Culture

282

1493

2.08

24.92

1.8

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

336

1895

1.98

24.91

3.0

2.1

29.6

29.7

0.14

330

1838

(3022217) INR in Platelet poor plasma by Coagulation assay

271

1416

2.10

24.79

20.5

22.7

inr

1.3

0.40

196

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

128

4.67

24.65

1.6

1.2

u/l

57.4

59.3

0.07

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

660

4603

1.75

24.61

3.6

3.4

ng/l

64.8

47.4

0.27

457

3048

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

4.99

24.00

1.6

1.5

umol/l

11.8

12.2

0.14

100

(3020393) Adenovirus Ag [Presence] in Stool

15.19

23.67

1.0

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

358

2096

1.92

23.64

4.9

3.0

mmol/l

2.5

2.4

2.94

324

1853

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

259

1355

2.09

23.53

2.0

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

450

2840

1.82

23.40

2.8

1.7

mg/l

1.7

1.1

1.68

380

2128

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

6.62

23.07

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

6.62

23.07

1.6

1.4

—

(3024928) Oxygen saturation in Venous blood

270

3.35

23.05

3.6

3.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

115

424

2.85

22.69

1.6

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

816

6122

1.69

22.65

4.5

3.4

estimate

0.0

0.80

220

1115

(3035350) Ketones [Presence] in Urine by Test strip

808

6062

1.68

22.29

4.4

3.4

estimate

0.0

0.50

216

1148

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

256

1364

2.05

22.05

2.0

1.8

—

(3044889) 12 lead EKG panel

1074

8709

1.73

21.98

4.0

3.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1094

8924

1.74

21.83

5.8

3.1

u/l

70.8

47.8

9.28

1041

8414

(3021601) Nitrite [Presence] in Urine by Test strip

805

6055

1.67

21.82

5.8

4.6

estimate

0.0

0.50

222

1175

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

106

385

2.88

21.49

1.9

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

161

725

2.36

21.06

1.6

1.5

—

(40761536) Microorganisms panel - Urine sediment

212

1071

2.13

20.99

5.5

3.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

351

2.94

20.97

1.6

1.4

ug/g

256.8

291.3

0.73

201

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

193

945

2.19

20.67

6.2

3.7

mmol/l

1.2

0.70

175

819

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

294

3.11

20.67

1.2

1.3

u/ml

262.7

247.4

0.20

181

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

180

862

2.23

20.36

5.7

4.1

ng/l

115.0

85.2

1.63

164

766

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

225

3.40

20.26

3.4

3.2

u/ml

963.7

2429.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

5.45

20.01

1.7

1.2

u/l

85.9

75.5

0.30

(3004716) Salmonella sp identified in Stool by Organism specific culture

155

704

2.33

19.86

1.5

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

5.54

19.83

1.7

1.2

u/l

29.1

17.7

0.54

(3003694) ABO and Rh group [Type] in Blood

530

3643

1.69

19.76

1.5

—

(1616796) Gas panel - Central venous blood

267

3.14

19.46

4.5

3.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

5.17

19.36

2.6

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

111

4.43

19.28

1.6

1.3

g/l

3.0

2.7

0.37

(3027135) IgG subclass 1 [Mass/volume] in Serum

111

4.43

19.28

1.6

1.3

g/l

7.8

7.1

0.34

(3024139) IgG subclass 3 [Mass/volume] in Serum

111

4.43

19.28

1.6

1.3

g/l

0.4

0.04

(4062490)

112

4.39

19.06

1.6

1.4

—

(3010421) pH of Blood

320

2.92

18.96

4.9

4.1

7.4

0.75

268

(3017354) Segmented neutrophils/100 leukocytes in Blood

121

4.23

18.95

2.6

3.7

61.7

54.3

1.27

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1368

12111

1.98

18.72

34.8

12.0

ml/min/173m2

84.3

84.7

0.23

1248

9959

(3002385) Erythrocyte distribution width [Ratio]

1257

10851

1.78

18.49

45.5

16.1

14.3

13.6

32.85

1247

10635

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

3.56

18.38

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

241

1336

1.95

18.35

4.3

u/l

216.8

251.5

3.28

230

1273

(3012501) Base excess in Blood by calculation

272

3.04

18.24

5.0

4.3

mmol/l

3.1

2.5

0.44

187

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

361

2277

1.76

18.16

3.8

3.6

ng/l

394.6

522.1

0.21

271

1683

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

306

2.91

18.10

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

4.80

17.81

6.6

4.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.60

17.33

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

282

2.94

17.13

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.55

17.11

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

470

3238

1.64

16.84

4.9

3.7

estimate

0.0

1.28

207

1122

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.86

16.68

3.1

3.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

287

2.88

16.60

6.9

3.0

kpa

8.7

8.3

1.26

268

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

374

2.64

16.52

5.8

4.1

mg/l

1.6

1.5

0.63

349

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.37

16.31

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

194

3.29

16.25

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

118

3.99

16.16

6.0

3.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

309

2.78

16.09

6.0

2.7

mmol/l

22.7

25.0

3.12

273

(3020891) Body temperature

108

459

2.45

16.02

9.7

4.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

182

970

1.99

15.41

4.8

2.5

ml/min/173m2

60.2

69.2

2.32

378

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.58

15.21

2.2

1.5

u/l

6.3

8.8

0.27

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

159

813

2.06

15.10

6.9

3.6

kpa

5.0

5.2

1.82

147

769

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

8.73

15.03

1.4

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

8.73

15.03

2.1

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

175

931

1.99

14.89

2.7

2.9

g/l

65.7

66.7

0.83

168

859

(3023183) Ammonium ion [Moles/volume] in Plasma

288

2.76

14.80

4.2

3.3

umol/l

31.4

34.9

0.84

248

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

141

700

2.11

14.47

1.7

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

151

774

2.05

14.23

6.6

3.6

mmol/l

0.3

1.7

2.51

106

581

(3009343) pH of Capillary blood

155

804

2.03

14.14

6.9

3.6

7.4

0.31

103

(3008757) Leukocyte morphology finding [Identifier] in Blood

138

3.48

13.64

2.5

4.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

105

475

2.30

13.55

1.2

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1481

13783

2.22

13.35

24.4

9.9

u/l

27.9

27.8

0.03

1458

13350

(3041672) Baker's yeast Ab [Presence] in Serum

28.61

12.97

1.1

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

251

2.74

12.87

2.9

2.4

16.6

16.4

0.16

129

(3011397) Hemoglobin [Presence] in Urine by Test strip

393

2746

1.57

12.70

3.5

3.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.50

12.38

1.0

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

493

3641

1.52

12.33

2.5

2.1

u/l

192.0

250.6

0.76

471

3443

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

399

2.33

12.18

2.6

2.4

g/l

3.0

3.1

0.08

321

(3004588) Protein electrophoresis panel - Serum or Plasma

143

762

1.96

12.07

2.3

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

2.28

12.00

2.6

2.4

g/l

7.5

7.2

0.62

331

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

2.28

12.00

2.6

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

421

2.28

12.00

2.6

2.4

g/l

3.9

3.8

0.38

316

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

391

2.32

11.86

2.7

2.4

g/l

10.1

10.4

0.30

340

(3021901) Oxygen saturation in Capillary blood

216

2.80

11.85

4.2

2.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

342

2.41

11.75

3.5

3.7

mg/l

40.3

45.4

0.20

276

(3034860) Kappa light chains.free [Mass/volume] in Serum

342

2.41

11.75

3.5

3.7

mg/l

72.0

72.6

0.01

275

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

12.08

11.75

1.2

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

336

2.42

11.74

3.5

3.7

ratio

1.3

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

120

608

2.05

11.66

3.6

2.7

e6/l

0.6

0.2

0.99

113

589

(40761511) CBC panel - Blood by Automated count

1455

13575

1.93

11.11

35.2

12.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

442

2.20

11.08

2.3

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

421

2.21

10.75

3.2

2.2

ug/l

454.4

406.7

0.07

399

(3011648) Oxygen content in Venous blood

104

3.52

10.75

2.6

2.8

10.8

11.0

0.09

104

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

270

2.51

10.68

1.4

1.5

u/ml

119.5

123.0

0.07

(3041096) Erythrocytes [Presence] in Urine by Automated

457

3414

1.48

10.49

4.6

3.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

486

2.11

10.48

2.4

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

599

4717

1.44

10.39

4.9

3.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

395

2874

1.50

10.31

1.3

1.2

u/ml

1.0

1.7

1.51

785

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

291

2.40

10.00

1.5

—

(3037121) Protein [Mass/volume] in Urine

443

2.12

9.85

4.5

3.8

g/l

0.3

0.21

198

(3021162) Amylase [Enzymatic activity/volume] in Specimen

6.87

9.74

3.3

3.1

u/l

722.4

3657.5

0.56

(3036603) Volume of Urine

3.89

9.69

2.6

1.4

1842.3

1808.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

253

2.43

9.14

3.2

4.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

132

3.00

9.07

3.2

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

6.30

9.00

2.7

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

338

2.22

8.98

2.4

g/l

37.0

37.8

0.43

299

(3006184) Hemoglobin [Mass/volume] in Capillary blood

253

2.38

8.68

2.5

2.3

g/l

129.3

131.5

0.24

190

(3026250) Tacrolimus [Mass/volume] in Blood

3.83

8.53

52.7

32.0

ug/l

6.3

7.5

2.37

(3016650) Hepatitis A virus Ab [Presence] in Serum

243

2.40

8.50

1.1

—

(3022313) Gas panel - Capillary blood

108

590

1.89

8.49

6.8

3.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.91

8.37

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.27

8.37

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

325

2.17

8.16

1.9

1.7

—

(3008898) HLA-B27 [Presence]

499

1.94

8.06

1.1

—

(3019977) pH of Arterial blood

3.88

7.98

2.2

3.6

7.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.26

7.81

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.26

7.81

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

366

2.07

7.74

2.5

2.6

g/l

0.0

1.3

5.22

329

(3013512) EKG study

439

3414

1.40

7.68

4.1

3.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

160

1010

1.65

7.66

2.5

2.4

ug/l

4.8

7.5

1.66

141

909

(3008295) Osmolality of Serum or Plasma

140

2.76

7.64

2.2

1.4

mosm/kgh2o

280.9

281.8

0.05

107

(3026493) Urate [Moles/volume] in Serum or Plasma

422

3263

1.40

7.63

3.5

2.6

umol/l

2785.7

5593.3

1.06

383

2874

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

314

2.15

7.63

2.0

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

158

2.64

7.56

2.3

2.2

umol/l

21.8

6.7

0.63

116

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

147

912

1.67

7.52

4.0

2.9

ng/l

176.1

184.4

0.09

127

828

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

233

2.32

7.41

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

139

2.70

7.18

1.8

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.04

6.91

2.4

2.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

103

2.95

6.87

2.5

1.5

g/l

0.8

1.0

2.60

103

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

282

2.13

6.78

1.3

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

1305

12136

1.44

6.75

38.8

14.0

38.1

40.5

16.73

963

9145

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.53

6.72

1.3

1.1

u/l

22.6

29.2

0.39

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

205

2.33

6.72

5.4

3.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.59

6.60

1.0

1.1

miu/ml

1306.4

1654.5

0.90

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

389

1.95

6.58

1.5

g/l

1.2

0.89

365

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

246

2.19

6.56

1.4

1.6

—

(3037756) Immunofixation for Serum or Plasma

228

2.23

6.46

1.4

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.95

6.44

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

405

3188

1.36

6.41

3.1

3.0

ng/l

2108.7

1297.9

0.94

349

2701

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

229

2.22

6.39

2.0

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.86

6.26

1.2

—

(3042733) HLA Ab [Presence] in Serum

3.69

6.20

3.6

5.1

—

(4306422)

207

2.26

6.14

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.13

6.09

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

992

8898

1.31

6.08

3.2

3.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

101

2.80

5.91

1.0

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

211

2.22

5.88

1.3

1.2

u/ml

4.1

4.8

0.17

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.53

5.81

4.0

2.1

—

(40761535) Cells panel - Urine sediment

147

982

1.55

5.58

3.8

3.2

—

(3028433) Virus identified in Specimen by Culture

3.84

5.54

1.1

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

385

1.86

5.48

1.7

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

123

2.55

5.47

1.3

1.4

—

32.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.25

5.45

2.0

3.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

293

0.24

5.44

1.4

1.6

—

(3017732) Neutrophils [#/volume] in Blood

131

858

1.57

5.42

3.7

3.1

e9/l

4.5

4.0

1.27

109

690

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

207

2.16

5.32

1.1

—

(3011412) CD3 cells [#/volume] in Blood

119

2.55

5.30

2.2

2.6

e9/l

1.1

1.2

0.18

(3021788) Differential panel - Synovial fluid

221

2.11

5.28

1.7

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.64

5.26

2.8

3.4

—

(3045716) Anion gap in Serum or Plasma

3.07

5.23

2.3

2.7

mmol/l

10.2

9.7

0.20

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

103

2.65

5.16

1.1

—

(3000330) Specific gravity of Urine by Test strip

551

1.69

5.16

4.4

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

342

1.88

5.15

2.0

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

210

2.13

5.14

1.4

1.2

u/ml

6.3

4.1

0.31

(3029075) Extractable nuclear Ab panel - Serum

3.91

4.99

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

123

2.47

4.97

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.75

4.95

2.6

2.8

e6/l

760.4

572.9

0.63

(3020682) Albumin/Creatinine [Ratio] in Urine

435

3580

1.30

4.87

4.7

4.1

mg/mmol

10.3

9.5

0.12

331

2314

(3006270) Folate [Moles/volume] in Blood

2.66

4.83

1.0

1.1

nmol/l

321.8

384.6

0.82

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.81

4.81

2.3

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.81

4.81

2.3

2.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

191

2.12

4.69

2.2

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

2.40

4.57

3.4

2.6

—

(4268621)

141

2.30

4.56

2.6

2.3

—

(3012516) Albumin [Mass/volume] in Urine

413

3402

1.29

4.55

3.7

3.4

mg/l

545.6

315.8

0.43

311

2212

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

262

2027

1.35

4.51

1.3

u/ml

3.9

12.2

3.34

798

(3009508) Creatinine [Moles/volume] in Urine

452

3779

1.27

4.41

3.7

3.3

mmol/l

8.7

8.0

2.05

392

3192

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.25

4.36

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

144

2.25

4.36

1.7

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

289

1.86

4.32

1.4

2.1

nmol/l

1.0

0.9

0.35

241

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.55

4.31

1.3

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1236

11615

1.30

4.29

5.2

4.5

mu/l

1.8

2.1

0.92

1154

10723

(3027570) Oxalate [Moles/time] in 24 hour Urine

11.71

4.27

1.1

1.5

umol/24h

237.4

334.8

—

(1761868) Lipid panel - Serum or Plasma

417

4953

0.79

4.27

3.0

2.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.89

4.26

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

114

2.39

4.24

2.2

2.3

43.0

45.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

112

751

1.53

4.22

4.2

3.6

pmol/l

4.4

4.6

1.68

103

674

(3023323) Follitropin [Units/volume] in Serum or Plasma

590

1.59

4.21

1.5

1.4

iu/l

23.3

26.1

0.33

501

(3019225) pH of Specimen

161

1162

1.43

4.20

7.1

4.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

351

1.77

4.19

1.9

2.3

mg/l

11.8

11.1

0.29

322

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

567

1.60

4.19

1.8

2.1

u/l

39.4

38.6

0.15

505

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.28

4.19

1.5

1.3

nmol/l

228.2

124.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.44

4.19

1.8

2.2

ug/l

59.6

58.4

0.02

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.93

4.17

2.6

3.4

u/ml

1438.6

750.7

0.82

(3007461) Platelets [#/volume] in Blood

1497

14524

1.61

4.16

55.9

19.3

e9/l

282.0

250.1

39.90

1479

14192

(44806118)

161

2.14

4.11

1.7

1.6

—

(44790047)

161

2.14

4.11

1.7

1.6

—

(44790048)

161

2.14

4.11

1.7

1.6

—

(44790049)

161

2.14

4.11

1.7

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.77

4.09

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

274

1.85

4.04

5.3

4.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.04

4.01

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

10.04

4.01

1.6

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

130

2.25

4.00

1.4

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

263

0.30

3.98

1.9

1.7

—

(3035941) MCH [Entitic mass]

1497

14537

1.59

3.98

55.6

19.2

29.7

30.3

23.51

1485

14343

(3024731) MCV [Entitic volume]

1497

14537

1.59

3.98

55.7

19.2

90.1

90.7

4.57

1486

14346

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.61

3.98

2.1

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.83

3.96

1.1

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.83

3.96

1.1

2.2

—

(3026361) Erythrocytes [#/volume] in Blood

1497

14539

1.58

3.95

55.8

19.3

e12/l

4.4

4.6

33.46

1475

14178

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

272

2157

1.32

3.94

1.3

iu/ml

19.0

32.4

2.63

672

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

151

2.14

3.91

2.3

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

482

1.63

3.91

2.9

2.3

u/l

4190.2

3470.3

0.07

203

(3010813) Leukocytes [#/volume] in Blood

1497

14544

1.58

3.89

56.0

19.3

e9/l

7.5

6.7

34.21

1475

14179

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

200

2590

0.74

3.87

2.9

2.8

ug/l

0.8

0.7

0.21

132

1595

(3000963) Hemoglobin [Mass/volume] in Blood

1497

14545

1.58

3.87

56.4

19.4

g/l

127.9

137.3

88.55

1486

14347

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

243

1.88

3.82

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

243

1.88

3.82

1.7

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1040

9632

1.23

3.77

4.4

3.8

pmol/l

14.6

14.7

0.60

959

8834

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.35

3.76

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

102

2.37

3.75

2.5

2.6

e6/l

1157.8

725.3

1.03

(3009214) Lutropin [Units/volume] in Serum or Plasma

433

1.65

3.74

1.5

1.4

u/l

10.4

7.9

0.58

353

(3000060) B lymphocytes [#/volume] in Blood

3.69

3.64

2.1

2.3

e6/l

3333.3

292.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.27

3.63

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

233

1836

1.32

3.53

1.8

1.9

1.5

0.00

204

1632

(3026389) Candida sp identified in Specimen by Organism specific culture

138

2.12

3.50

1.1

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.03

3.50

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.57

3.48

4.2

7.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.49

3.47

2.6

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

1.85

3.44

1.8

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

174

1.98

3.40

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.67

3.40

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.67

3.40

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.67

3.40

1.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.67

3.40

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

114

2.21

3.36

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

114

2.21

3.36

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

114

2.21

3.36

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

314

1.71

3.35

1.3

1.2

u/ml

3.9

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

1.96

3.35

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

2.63

3.30

1.2

1.3

nmol/l

134.1

147.2

0.51

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

942

0.62

3.27

1.2

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

1.89

3.26

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.35

3.25

1.8

2.2

11.2

13.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

379

1.63

3.24

1.2

—

(36660697) Celiac disease serology panel - Serum

136

1000

1.39

3.24

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.35

3.19

4.2

7.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

319

1.68

3.18

1.3

1.2

u/ml

10.1

11.4

—

(40768443) Skin Pathology biopsy report

510

1.54

3.14

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

400

1.60

3.08

2.7

—

(3042631) Mycobacterium sp identified in Specimen

161

1.94

3.00

3.3

2.7

—

(3023419) Bacteria identified in Sputum by Culture

161

1.94

3.00

3.3

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1378

0.70

3.00

1.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

111

1512

0.71

2.97

1.3

—

(40768446) Kidney Pathology biopsy report

2.60

2.87

1.8

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

632

0.58

2.86

1.6

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

150

1.95

2.86

2.1

1.6

54.0

61.2

0.39

101

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

324

1.63

2.77

1.6

2.0

iu/l

4.2

5.4

0.45

117

(3017817) Protein [Mass] in Urine collected for unspecified duration

104

2.13

2.75

2.5

2.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.38

2.73

2.6

1.3

u/ml

32.0

18.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.16

2.71

1.6

2.3

u/field

2.1

2.0

0.05

(3028717) Thiamine [Mass/volume] in Blood

6.02

2.70

1.0

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.17

2.61

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.17

2.61

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

141

1.93

2.61

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.61

2.57

1.1

1.2

104.0

98.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.61

2.57

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

200

1.77

2.57

1.5

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.12

2.49

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.12

2.49

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.12

2.49

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

117

882

1.35

2.44

1.1

1.2

iu/ml

93.1

140.9

1.23

349

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

138

1.90

2.41

1.0

1.1

—

(4281824)

110

2.01

2.41

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

297

1.60

2.41

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.62

2.36

3.2

3.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

111

2.00

2.36

2.0

1.4

38.6

31.2

0.38

(44816559) Phosphatidylethanol [Mass/volume] in Blood

299

1.59

2.35

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

147

1.85

2.33

1.9

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

105

2.01

2.31

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

219

0.41

2.30

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

254

1.63

2.28

1.6

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

141

1.86

2.28

1.5

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.16

2.25

1.6

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.06

2.22

1.2

1.1

—

(3024471) HLA-A [Type]

2.42

2.20

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

337

1.53

2.18

1.6

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

549

0.61

2.17

1.4

1.8

mg/l

3.0

3.5

0.41

389

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

101

1.99

2.16

2.1

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.30

2.15

1.5

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

260

1.59

2.10

2.4

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.57

2.10

1.7

1.3

ug/l

11.8

8.6

0.79

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.14

2.08

1.1

ratio

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.01

2.04

2.3

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

2.01

2.00

1.4

1.1

—

43.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

554

1.39

2.00

2.4

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

112

1.89

1.96

3.0

2.5

—

(3022621) pH of Urine by Test strip

757

1.33

1.93

3.2

2.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

308

3520

0.84

1.93

4.0

3.9

20.7

21.1

0.13

137

1548

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

219

1.61

1.92

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.06

1.91

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

530

0.63

1.90

1.9

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1232

12737

0.85

1.90

4.2

4.1

mmol/l

1.5

1.4

2.38

1146

11857

(3024932) HLA-DR beta [Type]

2.32

1.88

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

2.21

1.84

1.8

3.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.18

1.82

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.18

1.82

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

4.18

1.82

2.4

2.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.18

1.82

5.6

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

160

1.70

1.82

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

530

1.38

1.81

2.1

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

192

1.63

1.78

1.2

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.35

1.78

6.0

4.6

—

(3004775) Volume in Urine collected for unspecified duration

1.91

1.75

2.3

2.2

851.7

642.2

0.51

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.45

1.75

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

147

1.71

1.74

1.8

1.3

nmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

217

1.58

1.74

1.2

1.1

iu/ml

1.8

2449.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

347

0.57

1.74

1.8

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.51

1.74

1.3

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

118

1468

0.79

1.73

1.6

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

371

0.59

1.72

1.7

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

346

0.57

1.72

1.8

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

346

0.57

1.72

1.8

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.92

1.72

5.4

7.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

345

0.57

1.71

1.8

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.30

1.70

1.9

1.5

—

(3025130) Human papilloma virus identified in Specimen

157

1.67

1.66

1.4

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.11

1.65

1.7

3.1

—

(3017704) Immunofixation for Urine

2.04

1.64

1.3

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

105

831

1.28

1.63

1.4

1.3

u/ml

196.5

239.8

0.31

766

(3044941) Cell count panel - Synovial fluid

197

1.59

1.63

1.7

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.01

1.59

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

106

1.80

1.59

2.5

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.70

1.58

3.7

5.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.21

1.57

1.3

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.28

1.53

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1189

12273

0.87

1.53

4.1

3.8

mmol/l

1.5

1.3

8.24

1102

11378

(3019832) Treponema pallidum Ab [Presence] in Serum

112

1379

0.80

1.52

1.7

—

(4024509)

1.84

1.51

1.5

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

414

0.65

1.46

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

117

1.72

1.45

3.1

3.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.93

1.44

2.0

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.13

1.44

3.4

2.2

—

(3049717) Cytology report of Urine Cyto stain

475

1.34

1.42

2.3

2.7

—

(3012441) Differential panel - Pleural fluid

118

1.70

1.41

1.2

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

126

1.68

1.40

1.1

1.3

e6/l

3953.6

1842.0

0.56

(4015189)

2.42

1.39

2.7

2.8

—

(3050794) Legionella sp Ab [Presence] in Serum

2.95

1.36

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

257

1.45

1.34

1.2

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.92

1.33

1.2

1.1

iu/ml

184.3

203.6

0.12

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

168

1.56

1.32

2.3

2.4

—

(3045788) Cell count panel - Pleural fluid

1.74

1.31

1.2

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.51

1.30

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.10

1.30

1.8

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

281

0.60

1.29

1.9

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.09

1.27

1.3

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.09

1.27

1.3

1.8

—

(3005033) Fetal Nuchal fold Thickness US

279

0.61

1.26

1.8

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

162

1.55

1.26

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

284

2541

1.14

1.25

1.7

1.5

—

(3000492) Spirometry study

154

1314

1.19

1.24

1.6

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.41

1.24

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.41

1.24

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.41

1.24

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

314

0.63

1.24

2.0

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.97

1.22

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.05

1.22

1.3

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.64

1.21

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1250

12811

0.88

1.21

4.3

4.2

mmol/l

4.5

4.7

7.80

1171

11990

(3043238) Trisomy 21 risk [Likelihood] in Fetus

288

0.62

1.21

1.8

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.84

1.19

5.8

7.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

525

1.29

1.19

1.6

mu/l

299.7

294.9

0.05

477

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1270

12999

0.88

1.19

4.5

4.6

mmol/l

2.5

2.8

23.60

1181

12086

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

1.18

1.2

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.31

1.18

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.88

1.18

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

2.34

1.12

2.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

111

1.63

1.12

1.1

1.3

e6/l

4665.0

87585.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

119

1.60

1.12

1.1

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.79

1.11

2.1

1.7

—

(3014271) Vancomycin [Susceptibility]

1.87

1.07

3.6

2.5

—

(3000012) Reticulocyte production index

1.89

1.01

1.6

1.9

—

(3034426) Prothrombin time (PT)

1.88

1.00

1.6

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

135

0.52

0.98

1.6

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.18

0.98

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

1.80

0.96

3.2

3.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.94

2.0

1.6

—

(3035880) pH of Pleural fluid

1.78

0.94

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

287

1.33

0.92

1.1

1.6

e6/l

52.9

22.5

0.29

224

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

287

1.33

0.92

1.1

1.7

e6/l

2062.3

733.4

0.40

230

(3023410) Appearance of Cerebral spinal fluid

134

1.50

0.92

1.2

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

270

1.34

0.91

1.1

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

262

1.34

0.90

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

262

1.34

0.90

1.1

—

(4211845)

1.79

0.88

4.3

2.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.76

0.83

1.5

3.6

umol/l

41.4

125.4

—

(3044927) Protein electrophoresis panel - Urine

129

1.48

0.83

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

414

4415

0.92

0.83

4.4

4.5

ug/l

2.4

2.3

0.17

368

3978

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

364

1.27

0.82

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

302

1.30

0.81

1.8

1.6

e6/l

9197.8

13240.0

0.66

226

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

142

1599

0.88

0.78

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

115

1.48

0.77

4.6

5.2

u/ml

50.9

72.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

799

0.83

0.76

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.76

0.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

289

2675

1.10

0.74

4.3

3.7

kg/l

1.0

1.26

366

(3033799) Differential panel - Peritoneal fluid

1.85

0.73

1.1

2.2

—

(3016879) Cocaine [Presence] in Urine

611

0.81

0.73

2.3

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

202

1.34

0.72

1.0

u/ml

1.8

2.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

0.72

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.80

0.72

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

159

1767

0.89

0.72

2.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.62

0.71

2.9

2.6

—

(3012565) Volume of 24 hour Urine

1.62

0.71

2.5

2.6

1839.1

2004.5

0.18

(1001926) Buprenorphine [Presence] in Urine by Screen method

520

0.80

0.70

2.4

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

715

0.83

0.69

2.0

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

650

0.82

0.69

2.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

157

0.63

0.69

1.0

1.1

—

(40768793) Breast Pathology biopsy report

262

0.72

0.69

1.0

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.85

0.68

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.85

0.68

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.85

0.68

1.2

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.85

0.68

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.85

0.68

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

659

0.83

0.68

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.52

0.66

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

295

1.26

0.65

2.6

2.4

ug/min

46.7

108.3

1.66

182

(3027008) Opiates [Presence] in Urine

656

0.83

0.65

2.2

—

(3027944) Amphetamines [Presence] in Urine

645

0.83

0.65

1.4

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.59

0.65

3.0

2.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.73

0.64

1.0

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.73

0.64

1.0

1.2

ug/l

1.5

8.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.59

0.61

1.0

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.60

0.61

4.8

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

105

1.43

0.60

1.8

2.0

—

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.54

0.59

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.46

0.58

1.0

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.72

0.57

1.0

1.3

mmol/l

4.4

3.6

—

(3011288) Drugs identified in Urine by Screen method

452

0.81

0.57

3.2

3.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.56

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.62

0.55

1.7

1.1

60.8

30.6

—

(3044007) Cell count panel - Peritoneal fluid

1.62

0.55

1.2

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.45

0.55

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.58

0.54

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.49

0.53

1.5

2.0

—

(40768795) Lymph node Pathology biopsy report

108

1.39

0.53

1.1

1.2

—

(4010399)

857

1.13

0.52

1.6

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

134

0.67

0.52

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

402

0.82

0.51

1.7

1.4

—

(3024263) Appearance of Synovial fluid

1.41

0.51

1.9

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.50

0.49

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.52

0.48

1.6

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

157

1448

1.09

0.48

13.3

6.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1184

11659

1.06

0.47

6.2

5.3

mmol/mol

40.2

39.4

1.86

1106

10886

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.41

0.47

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

120

1.34

0.46

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

1.16

0.46

1.2

1.3

miu/ml

228.8

217.3

0.08

213

(3051593) INR in Capillary blood by Coagulation assay

1.43

0.46

30.9

13.8

—

(3015183) Erythrocyte sedimentation rate

1.43

0.45

1.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

138

1498

0.91

0.45

4.0

4.2

34.6

31.5

2.53

106

1051

(3017446) Testosterone [Moles/volume] in Serum or Plasma

129

1183

1.10

0.45

2.5

2.2

nmol/l

11.4

13.4

2.45

116

1059

(3020191) Ethanol [Moles/volume] in Serum or Plasma

112

1.34

0.44

1.5

1.6

promille

1.9

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

348

3321

1.06

0.44

1.8

1.6

mmol/l

1.6

1.4

1.82

297

2818

(4034850)

387

1.17

0.43

11.9

9.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.38

0.42

1.0

1.1

u/ml

1.5

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.56

0.42

1.4

2.2

umol/l

12.7

14.7

—

(3045142) Bone marrow Pathology biopsy report

140

1.29

0.42

1.1

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

909

0.90

0.41

2.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

733.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.1

—

(40768800) Prostate Pathology biopsy report

249

0.80

0.40

1.3

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

3.1

—

0.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.39

0.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.39

0.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

1.25

0.38

1.1

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

133

1.28

0.38

1.0

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.35

0.37

2.2

1.4

41.4

29.7

—

(3045424) Erythrocytes [Presence] in Urine

216

1.21

0.37

1.6

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

207

1.21

0.36

2.9

3.1

nmol/l

1.1

0.8

0.40

167

(40765096) Chromosome analysis panel by Banding

1.33

0.33

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

209

0.81

0.32

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.35

0.31

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.73

0.31

1.0

1.1

—

(4094501)

324

1.15

0.30

1.1

—

(21494434) Karyotype in Bone marrow

111

1.26

0.30

1.0

1.3

—

(3047189) Immunofixation for 24 hour Urine

1.23

0.29

3.7

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.23

0.29

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

130

1.23

0.28

1.2

1.4

pmol/l

69.6

67.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

355

1.13

0.28

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1223

12342

0.96

0.27

4.4

4.2

mmol/l

6.0

5.9

2.58

1122

11351

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.21

0.26

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

197

1.17

0.26

1.1

1.2

—

(4198724)

0.67

0.26

1.4

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.67

0.26

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.20

0.25

4.6

2.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.28

0.24

1.7

1.5

u/l

11.0

13.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

154

1468

1.05

0.23

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

158

0.82

0.23

1.5

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.25

0.22

1.8

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.22

0.22

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

104

0.77

0.21

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

173

1.16

0.21

1.5

—

(3019174) dRVVT (LA screen)

0.00

0.20

0.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.20

0.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.25

0.20

2.0

1.2

107.7

113.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

111

0.81

0.20

1.2

1.1

mg/l

38.6

37.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

665

0.93

0.20

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

747

0.93

0.20

1.6

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

366

1.10

0.19

1.8

1.9

pmol/l

197.4

214.0

0.57

345

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.13

0.18

1.3

1.1

—

11.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

1.20

0.18

1.2

u/ml

0.1

0.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

393

0.91

0.17

1.8

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

110

1.18

0.17

1.2

1.4

mmol/l

8.9

12.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.71

0.16

1.0

1.1

—

(1002224) Polysomnography panel

628

0.94

0.16

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.78

0.15

1.0

1.2

u/l

17.0

11.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.13

0.15

1.1

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

159

1.13

0.15

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

267

1.09

0.13

3.6

3.7

mg/l

26.5

26.6

0.00

168

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

270

0.92

0.10

1.1

u/ml

0.2

1.9

2.61

111

(3041806) Other cells [#/volume] in Blood by Manual count

1.07

0.08

3.0

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.83

0.08

1.2

nmol/l

26.2

32.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.78

0.08

1.6

2.2

—

216.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.08

0.08

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.08

0.08

2.1

2.0

nmol/l

132.4

142.0

—

(40768806) Pleura Pathology biopsy report

123

0.89

0.08

1.1

1.5

—

(3004451) EKG impression Narrative

1.06

0.08

1.7

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

183

1863

0.98

0.08

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.03

0.07

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

245

0.94

0.07

1.1

u/ml

4.9

6.8

0.37

122

(44813793)

0.83

0.07

1.0

—

(4027681)

0.88

0.06

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.89

0.06

1.0

1.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

105

0.86

0.06

1.0

mg/l

224.4

249.1

—

(4146454)

129

1.09

0.05

2.1

2.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

198

1.06

0.05

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

288

1.04

0.04

3.0

2.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

459

1.02

0.03

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

198

0.96

0.02

1.3

1.4

u/l

22.8

21.9

0.05

165

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

254

1.02

0.00

2.0

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

104

0.96

0.00

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

107

1.03

0.00

16.9

16.5

nmol/l

852.8

814.8

0.14

102

(3008401) Mugwort IgE Ab [Units/volume] in Serum

235

1.02

0.00

1.1

u/ml

0.2

1.5

1.44

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.91

0.00

6.4

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.91

0.00

3.2

3.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

2.6

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.97

0.00

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.02

0.00

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_JFH – Total colectomy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Total colectomy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Total colectomy (OPER_JFH)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints